March 2022

Biomarker testing has become an incredible tool in helping doctors identify the right treatment options for a patient. Specifically, oncologists are using it as a first step in identifying which medications might work for a cancer patient. Precision medicine can provide targeted treatment and a better chance of survival. Through this process, tissues are reviewed for biological markers revealing specifics about their form of cancer – allowing their care team to choose the treatment that has proven most effective for that marker. 

IOS President Sakeer Hussain, MD, an oncologist from Council Bluffs, authored an article on the topic of biomarkers including how they support patient-centered care, the need for increased awareness, rapid innovation and patchwork standards, and the barriers of coverage, delays, and cost. 

December 21, 2021

Genetic counselors are healthcare professionals who have expert knowledge of how genetics contribute to the likelihood of developing disease; they help individuals understand how their unique genetic makeup may affect their health or the health of their family members. They use their knowledge to counsel patients about whether to get tested, and they help interpret test results.

As part of its educational program to address the barriers to obtaining genetic testing and counseling in cancer programs and practices, the Iowa Oncology Society has created a consortium of multidisciplinary providers and stakeholders to discuss and address these issues.

August 2021

Iowa Oncology Society (IOS) President Matthew Obinna Nwaneri, MD, MBA, weighs in on the importance of a booster vaccination, especially for immunocompromised patients. "COVID-19 is likely going to be with us for much longer than anticipated, and a new norm may be learning to live with COVID-19 with its expected periodic mutations/variants over the long term. Our currently available vaccinations (despite their uncertainties) may be our only short-term protection, for now. Everyone should strive to be vaccinated."